Skip to content

Cancer Treatment in China for International Patients

Cancer Treatment in China for International Patients banner: hospitals, medicines and public hospital prices

This guide explains how cancer is treated in China, which hospitals hold national titles for cancer care, which cancer medicines are approved, and what public hospitals charge. We use Chinese government sources and the hospitals’ own statements only.

Key points
  • We list 26 hospitals in 22 cities. Each holds a national title for cancer care, such as the National Cancer Center or a National Clinical Key Specialty. Every title links to its source.
  • China has approved 10 CAR-T products and many newer cancer medicines. Each one is approved only for certain cancers and stages.
  • One IMRT radiotherapy session costs ¥1,200–1,900 at public hospitals in the four provinces we checked. Prices of medicines agreed with China’s national insurance office are not public.
  • No hospital can promise a cure. Never pay to join a drug trial.

How cancer is treated in China

Chinese hospitals treat cancer with a team of doctors from different fields. This is called a multidisciplinary team (MDT). The team plans care for each patient and can use surgery, radiotherapy, chemotherapy, targeted drugs and immunotherapy. National guidelines ask for this team approach, for example the lung cancer guideline.

China has national treatment guidelines for many cancers. The 2022 set covers 21 cancer and blood diseases, as listed in the National Health Commission notice.

Doctors must follow the approved label and may use a medicine outside it only in special cases. Some targeted medicines need a gene test first. These rules are in the national guide to new cancer medicines.

Traditional Chinese medicine next to cancer care

Some cancer hospitals in China offer traditional Chinese medicine (TCM) alongside standard cancer care. TCM should not replace surgery, radiotherapy or cancer medicines when you need them. Some herbs and supplements can interact with cancer drugs, so tell your cancer team about everything you take.

How we choose these hospitals

A hospital is on this page only if it holds a national title for cancer care. These titles are the National Cancer Center and the national list of hospitals chosen to build regional cancer centres. They also include a national regional medical centre project for cancer and a National Clinical Key Specialty in oncology, thoracic surgery or haematology. For a key specialty we print the exact title the hospital uses, including “construction project”. A few hospitals are listed because their own WeChat account states their result in a national specialty ranking. We do not rank hospitals.

Hospitals for cancer care, by city

Swipe the table sideways to see all columns.

CityHospitalNational titleInternational department
BeijingCancer Hospital Chinese Academy of Medical Sciences
中国医学科学院肿瘤医院
National Cancer Center source 2
Chosen to build regional cancer centres (2022)
National Clinical Key Specialty: oncology, thoracic surgery
国家临床重点专科
—
BeijingBeijing Cancer Hospital
北京大学肿瘤医院
Chosen to build regional cancer centres (2022)
National Clinical Key Specialty: oncology
国家临床重点专科
—
BeijingChinese PLA General Hospital
中国人民解放军总医院
Nominated for oncology, thoracic surgery and haematology in the 2023 Fudan specialty reputation ranking (the hospital’s own WeChat post, 2024)—
ShanghaiFudan University Shanghai Cancer Center
复旦大学附属肿瘤医院
Chosen to build regional cancer centres (2022)
National Clinical Key Specialty: oncology
国家临床重点专科
—
GuangzhouSun Yat-sen University Cancer Center
中山大学肿瘤防治中心
Chosen to build regional cancer centres (2022)Yes
GuangzhouGuangzhou Fuda Cancer Hospital
广州复大肿瘤医院
National Clinical Key Specialty: oncology
国家级临床重点专科
Its oncology key specialty passed the 2018 national evaluation (the hospital’s own WeChat post, 2018)
Yes
TianjinTianjin Medical University Cancer Institute and Hospital
天津市肿瘤医院
Chosen to build regional cancer centres (2022)
National Clinical Key Specialty: thoracic surgery, oncology
国家临床重点专科
Yes
ChangshaHunan Cancer Hospital
湖南省肿瘤医院
National Clinical Key Specialty: oncology
国家级临床重点专科
—
ChengduSichuan Cancer Hospital
四川省肿瘤医院
National Clinical Key Specialty: oncology (2014)
国家临床重点专科
—
ChongqingChongqing University Cancer Hospital
重庆大学附属肿瘤医院
National Clinical Key Specialty: its medical oncology department (department’s own WeChat)
国家临床重点专科
—
FuzhouFujian Cancer Hospital
福建省肿瘤医院
National regional medical centre project (cancer), with Fudan University Shanghai Cancer Center (2023)—
HangzhouZhejiang Cancer Hospital
浙江省肿瘤医院
7th for oncology in the Fudan specialty reputation ranking (the hospital’s own WeChat post, 2022)—
HarbinHarbin Medical University Cancer Hospital
哈尔滨医科大学附属肿瘤医院
National Clinical Key Specialty construction project: thoracic surgery (2021)
国家级临床重点专科建设项目
—
HohhotPeking University Cancer Hospital Inner Mongolia Hospital
北京大学肿瘤医院内蒙古医院
National regional medical centre project (cancer), with Beijing Cancer Hospital (2022)—
JinanCancer Hospital of Shandong First Medical University
山东第一医科大学附属肿瘤医院(山东省肿瘤防治研究院、山东省肿瘤医院)
National Clinical Key Specialty construction unit: oncology
国家临床重点专科建设单位
Also gives proton therapy; its proton system has been in full use since 2024 (the hospital’s own WeChat post, 2024)
—
KunmingYunnan Cancer Hospital
云南省肿瘤医院
National Clinical Key Specialty construction project: thoracic surgery
国家级临床重点专科建设项目
—
LanzhouGansu Provincial Cancer Hospital
甘肃省肿瘤医院
National regional medical centre project (cancer), with Sun Yat-sen University Cancer Center (2022)—
NanjingJiangsu Cancer Hospital
江苏省肿瘤医院
National Clinical Key Specialty: thoracic surgery
国家级临床重点专科
—
NanningAffiliated Tumor Hospital of Guangxi Medical University
广西医科大学附属肿瘤医院
National Clinical Key Specialty capacity-building project: oncology
国家临床重点专科能力建设项目
—
ShenyangThe First Hospital of China Medical University
中国医科大学附属第一医院
National regional medical centre project (cancer), with Cancer Hospital Chinese Academy of Medical Sciences (2020)—
ShenyangLiaoning Cancer Hospital & Institute
辽宁省肿瘤医院
National Clinical Key Specialty construction project: thoracic surgery (2023)
国家临床重点专科建设项目
—
ShenzhenCancer Hospital, Chinese Academy of Medical Sciences, Shenzhen Center
中国医学科学院肿瘤医院深圳医院
National regional medical centre project (cancer), with Cancer Hospital Chinese Academy of Medical Sciences (2022)—
TaiyuanShanxi Provincial Cancer Hospital
山西省肿瘤医院
National regional medical centre project (cancer), with Cancer Hospital Chinese Academy of Medical Sciences—
UrumqiAffiliated Tumor Hospital of Xinjiang Medical University
新疆医科大学附属肿瘤医院
National Clinical Key Specialty: oncology
国家级临床重点专科
—
WuhanHubei Cancer Hospital
湖北省肿瘤医院
National Clinical Key Specialty: oncology
国家临床重点专科
—
ZhengzhouHenan Provincial Cancer Hospital
河南省肿瘤医院
National Clinical Key Specialty: oncology, thoracic surgery
国家临床重点专科
National regional medical centre project (cancer), with Cancer Hospital Chinese Academy of Medical Sciences (2022)
—

Public hospitals show their fees in their WeChat mini-program. Check the current fee there before you travel.

Cancer types

People ask about many cancer types. For each one, the table names examples of newer medicines approved in China. Each example links to the approval record of China’s drug regulator. Each medicine is approved for certain stages or after certain treatments only. Ask your doctor which one fits your case.

Swipe the table sideways to see all columns.

Cancer typeExamples of newer medicines approved in ChinaHospitals on this page
LungSee the Lung cancer sectionThoracic-surgery titles: Beijing · Tianjin · Harbin · Kunming · Nanjing · Shenyang · Zhengzhou
Breastpertuzumab; trastuzumab deruxtecan; trastuzumabAny hospital in the city table
Prostateenzalutamide; apalutamide; darolutamideAny hospital in the city table
Stomachnivolumab; disitamab vedotin; tislelizumab; satricabtagene autoleucel (CAR-T, for CLDN18.2-positive stomach cancer)Any hospital in the city table
Liverlenvatinib; atezolizumab with bevacizumab; sintilimabAny hospital in the city table
Colorectalbevacizumab; cetuximab; fruquintinibAny hospital in the city table
Cervicalbevacizumab; cadonilimabAny hospital in the city table
Ovarianolaparib; niraparib; bevacizumabAny hospital in the city table
Melanomapembrolizumab; toripalimab; trametinib with dabrafenibAny hospital in the city table
Sarcomaanlotinib with benmelstobart, for alveolar soft part sarcomaAny hospital in the city table
Mesotheliomanivolumab with ipilimumabAny hospital in the city table
Leukaemiazanubrutinib for chronic lymphocytic leukaemia; CAR-T for B-cell leukaemia (see Blood cancers and CAR-T)See Blood cancers and CAR-T
Lymphomazanubrutinib; CAR-T (see Blood cancers and CAR-T)See Blood cancers and CAR-T
Multiple myelomadaratumumab; lenalidomide; CAR-T (see Blood cancers and CAR-T)See Blood cancers and CAR-T
PancreaticnimotuzumabAny hospital in the city table
Oesophagealcamrelizumab; tislelizumab; toripalimabThoracic-surgery titles: Beijing · Tianjin · Harbin · Kunming · Nanjing · Shenyang · Zhengzhou
Brain tumour (glioma)None in the national guide to new cancer medicines (2024 edition)Any hospital in the city table

The titles on this page are for oncology, thoracic surgery and haematology. Thoracic surgery matches lung and oesophageal cancer, and haematology matches blood cancers. For the other types, every hospital in the city table holds a title for cancer care in general.

Lung cancer

Surgery is an important treatment for early-stage non-small cell lung cancer (NSCLC) when the tumour can be removed safely. It is also used in some stage III cases. The plan depends on the stage, the tumour’s features and the patient’s general health. Small cell lung cancer is usually treated with medicines and radiotherapy. Surgery is used only in some very early cases. Other treatments for lung cancer are radiotherapy, chemotherapy, targeted drugs and immunotherapy.

Some targeted drugs work only when the cancer has a certain gene change, such as an EGFR mutation. When a gene test is used to choose treatment, China’s guidance requires an approved test method. If you have test results from abroad, ask the hospital if they meet the rules for the medicine it suggests. Results from abroad are not always accepted, and they do not always need to be repeated.

These immunotherapy medicines (PD-1 and PD-L1 medicines) are approved in China for some lung cancers.

Two more hospitals in Shanghai report their lung cancer surgery in their own WeChat posts.

Swipe the table sideways to see all columns.

HospitalCityWhat its own WeChat says
Shanghai Pulmonary Hospital
上海市肺科医院
ShanghaiIts thoracic surgery was 2nd in the Fudan specialty reputation ranking (2021 list). (the hospital’s own WeChat post, 2022)
Shanghai Chest Hospital
上海市胸科医院
ShanghaiIts thoracic surgery is a national key clinical specialty, in the hospital’s words (国家重点临床专科). (the hospital’s own WeChat post, 2026)

Blood cancers and CAR-T

CAR-T is a treatment made from the patient’s own immune cells (T cells), changed in a lab to attack the cancer. China’s drug regulator has approved these 10 CAR-T products.

Swipe the table sideways to see all columns.

CAR-T productApproved forYearNMPA source
axicabtagene ciloleucel
阿基仑赛
Large B-cell lymphoma2021record 1 · record 2
relmacabtagene autoleucel
瑞基奥仑赛
Large B-cell, follicular and mantle cell lymphoma2021record 1 · record 2 · record 3
equecabtagene autoleucel
伊基奥仑赛
Multiple myeloma2023record 1 · record 2
inaticabtagene autoleucel
纳基奥仑赛
Adult B-cell leukaemia; large B-cell lymphoma2023record 1 · record 2 · record 3
zevorcabtagene autoleucel
泽沃基奥仑赛
Multiple myeloma2024record 1 · record 2
ciltacabtagene autoleucel
西达基奥仑赛
Multiple myeloma2024record 1 · record 2
ranicabtagene autoleucel
雷尼基奥仑赛
Large B-cell lymphoma2025record 1 · record 2
puzolcabtagene autoleucel
普基奥仑赛
B-cell leukaemia, ages 3–212025record 1 · record 2
satricabtagene autoleucel
舒瑞基奥仑赛
Stomach cancer (CLDN18.2-positive)2026record 1 · record 2
pocabtagene autoleucel
泊基奥仑赛
Large B-cell lymphoma2026record 1 · record 2

Most of these are approved only when the cancer has come back or did not respond to earlier treatment.

Some people’s lymphoma comes back or does not respond to treatment. For some of them, national guidelines list two options: a blood stem-cell (haematopoietic) transplant or CD19 CAR-T. CD19 CAR-T targets a marker on B cells. The choice depends on the type of lymphoma, earlier treatment, the response and general health. A proven blood or bone-marrow transplant is not the same as an unproven stem-cell treatment sold as a cancer cure. See the lymphoma guideline. See also the large B-cell lymphoma guideline.

CAR-T can cause serious side effects. It needs a trained hospital team and close monitoring. Each product in the table is approved for specific uses, so the cancer name alone does not show that you can have it. Ask the hospital which case applies: an approved product used as approved, an approved product used off-label, or part of an authorised study. An offer that is not on this list is not automatically a real clinical trial. Ask for the approval, study and consent papers, and be careful with promises of a cure.

These hospitals report their results in blood cancers in their own WeChat posts.

Swipe the table sideways to see all columns.

HospitalCityWhat its own WeChat says
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
中国医学科学院血液病医院(中国医学科学院血液学研究所)
TianjinIt has led the Fudan haematology ranking for 13 years (2021 list). (the hospital’s own WeChat post, 2022)
The First Affiliated Hospital of Soochow University
苏州大学附属第一医院
SuzhouIts haematology was 3rd in the Fudan specialty reputation ranking (2020 list). (the hospital’s own WeChat post, 2021)

Treatments available in China

Proton and heavy-ion therapy

Proton and heavy-ion (carbon-ion) therapy are special types of radiotherapy. They suit some cancers, not all, and are not better than standard radiotherapy for every cancer. Your doctor decides. Each centre below shows its service in its own WeChat posts or in the registration of its system at China’s drug and device regulator.

Swipe the table sideways to see all columns.

CentreCitySystemSinceSources
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
上海交通大学医学院附属瑞金医院
ShanghaiProton therapy with China’s first home-made proton system, model SAPT-PS-01. NMPA registration: 2022.In full use since November 2023hospital post 1 · NMPA registration
Shanghai Proton and Heavy Ion Center
上海市质子重离子医院
ShanghaiProton and carbon-ion therapy; the first hospital in China with both. More than 100 patients from abroad, its own post says. Parent hospital: Fudan University Shanghai Cancer Center.In full operation since May 2015hospital post 1
Wuhan Union Hospital
华中科技大学同济医学院附属协和医院
WuhanProton therapy. System: Varian ProBeam 360. NMPA registration: 2025.In use; more than 150 patients treated by March 2026hospital post 1 · hospital post 2 · NMPA registration
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
中国科学技术大学附属第一医院
HefeiProton therapy at its ion medical centre (Hefei Ion Medical Center). System: Varian ProBeam.Open since April 2024hospital post 1
Zibo Wanjie Cancer Hospital
淄博万杰肿瘤医院
ZiboProton therapy; it brought in its proton system in 2001, its own post saysIn clinical use since December 2004hospital post 1
Hebei Yizhou Cancer Hospital
河北一洲肿瘤医院
HebeiProton therapy at its proton medical centre; a fifth treatment room opened in August 2024In use (2024)hospital post 1
Gansu Wuwei Tumor Hospital
甘肃省武威肿瘤医院
WuweiCarbon-ion (heavy-ion) therapy with China’s own system, model HIMM-01-GS-WW-1. NMPA registration: 2019. Its Lanzhou heavy-ion centre opened in November 2024.Treating patients since March 2020hospital post 1 · hospital post 2 · NMPA registration

Other centres in China also give proton therapy. We add more centres when we find the regulator’s registration or the hospital’s own post about the service. We do not list systems that are still in clinical trials.

What is not established care

Research is not the same as proven treatment. If a hospital offers you research, ask for the study registration, the ethics approval, the consent papers and a clear account of the risks and other options. An unapproved cell therapy is not automatically a real study. Registration also does not prove that a treatment works. China’s rules on stem-cell research are in the national stem-cell research rules.

In drug-registration trials under China’s clinical-trial rules, the sponsor must give the trial medicines free and pay for trial-related medical tests. This does not make all care or travel free. Ask for the covered and uncovered costs in writing. These duties are in the 2026 clinical-trial rules.

Be careful with research sold as a proven cure. No hospital can guarantee a cure for one patient.

Reviewed by Dr. Arif Shah, MBBS · 2026-11-16.

Cost of cancer care in China

These are government prices for public tertiary (grade 3) hospitals in Beijing, Shanghai, Guangdong and Tianjin, from documents in force in 2024–2026. Beijing and Guangdong set maximum prices. Guangdong’s radiotherapy prices are Guangzhou’s. The median is the middle price of the four provinces.

Swipe the table sideways to see all columns.

ItemMedianRangeProvinces
Drip (infusion), per drip — chemotherapy is given this way¥12¥5–¥184
3D conformal radiotherapy, per session¥1,125¥850–¥1,3104
IMRT (intensity-modulated radiotherapy), per session¥1,745¥1,200–¥1,9004
CT (computed tomography) scan with contrast, per body part¥297.5¥203–¥3054
MRI (magnetic resonance imaging) with contrast, per body part¥550¥455–¥5554
PET-CT (positron emission tomography with CT), whole body¥5,000same in all 44
Needle biopsy (chest)¥112¥65–¥1774
Pathology diagnosis¥137.5¥110–¥1504
Immunohistochemistry, per slide¥185¥150–¥2524
Hospital bed, 3-bed room, per day¥68.5¥64–¥704

Medicines, tests and other services are charged on top. Prices of medicines agreed with China’s national insurance office are not public. Check the current fee in the hospital’s WeChat mini-program.

Examples: what a course of care can cost

These examples multiply the government prices above by a course length from China’s national treatment guidelines. They show hospital service charges only. They are illustrations, not a standard course and not your bill. Your doctors decide your tests and treatment.

First tests before treatment. This is an illustration: CT with contrast of 2 body parts, a needle biopsy, a pathology diagnosis and 4 immunohistochemistry slides. It is not a checklist; your doctors decide which tests you need and how many. A whole-body PET-CT, if your doctor asks for one, adds ¥5,000.

Radiotherapy to the whole breast after surgery, short course. This is an illustration: 15 sessions of IMRT, one of the schedules in the national breast cancer guideline. Your doctors choose the schedule and technique. The total includes the one-off fees for simulation, planning and plan verification, from one plan (lower figure) up to the limit the price documents allow (higher figure).

Radiotherapy to the whole breast after surgery, standard course. This is an illustration: 25 sessions of IMRT, one of the schedules in the national breast cancer guideline. Your doctors choose the schedule and technique. The total includes the one-off fees for simulation, planning and plan verification, from one plan (lower figure) up to the limit the price documents allow (higher figure).

Chemotherapy after lung cancer surgery. The national lung cancer guideline recommends 4 cycles of platinum-based chemotherapy after surgery for stage II–III non-small cell lung cancer. We show no total, because the length of each cycle, the number of drips and any hospital stay depend on the medicines your doctors choose. Ask the hospital for a written estimate.

Swipe the table sideways to see all columns.

ExampleMedianBeijingShanghaiGuangdongTianjin
First tests before treatment¥1,547¥1,256¥1,664¥1,945¥1,430
Breast radiotherapy, 15 sessions¥29,936–32,408¥34,740–39,080¥26,704–27,328¥33,168–37,488¥21,625–24,150
Breast radiotherapy, 25 sessions¥47,386–49,858¥53,740–58,080¥43,504–44,128¥51,268–55,588¥33,625–36,150

One-off radiotherapy fees. Each price document limits how often these fees may be charged in one course. In Beijing, the document allows planning up to 2 times per course, and verification no more often than planning. In Shanghai, the document allows simulation, planning and verification up to 2 times each per course. In Guangdong, the document allows planning up to 2 times per course (Guangzhou prices). In Tianjin, the document allows planning and verification up to 2 times per course, for a plan in one body area. Being allowed to charge a fee twice does not mean you will need it twice.

Planning your treatment trip

  1. Prepare your records. Collect your doctor’s reports, your pathology and gene-test results, and your scans (the reports and the image files).
  2. Choose a hospital and contact it. Use the city table above. To see which hospitals list an international department, use our table of international patient services.
  3. Get your visa. China has no special medical visa. Most patients use an S2 visa with an invitation letter from the hospital (our visa guide is linked below this page). Some nationalities can enter without a visa.
  4. Plan how long you stay. It depends on the treatment and your plan. For CAR-T, national guidance describes living near the hospital for about four weeks after treatment; the exact rule depends on the product. Ask the hospital for its plan.
  5. Plan how to pay. Hospitals usually ask for a deposit before a stay (our guide to paying at hospitals is linked below this page). Some insurers pay the hospital for you: see direct billing by insurer.
  6. Get language help. Our guide to medical interpreters is linked below this page.
  7. Going home. Before you leave, ask the hospital for copies of your reports and your discharge summary, so your doctor at home can go on with your care.

Often searched by international patients

HospitalCity
Modern Cancer Hospital Guangzhou
广州现代医院
also known as Modern Hospital Guangzhou
Guangzhou

Frequently asked questions

Which hospital is best for cancer treatment in China?

We do not rank hospitals. The city table on this page lists hospitals with national titles for cancer care. Choose by your cancer type, the city and whether the hospital has an international department.

How much does cancer treatment cost in China?

It depends on the cancer, the plan and the city. We checked public hospitals in four provinces.
One IMRT radiotherapy session: RMB 1,200–1,900.
A whole-body PET-CT scan: RMB 5,000.
Ask the hospital for a written estimate before you travel.

Is cancer treatment free for foreigners in China?

No, foreign patients usually pay for their own care. China’s national medical insurance covers people who are insured in China. Foreign patients pay the hospital themselves or use their own insurance. Some insurers pay the hospital directly.

How do I come to China for cancer treatment? Is there a medical visa?

China has no special medical visa. Most patients use an S2 visa with an invitation letter from the hospital. Some nationalities can enter without a visa. The section on planning your treatment trip shows each step.

Can a family member stay with the patient in hospital?

Each hospital sets its own rules, and they change. For example, one cancer hospital in Tianjin lets one family member stay with a pass from the nurses’ desk, as stated in its 2019 notice. Ask the ward about the current rule when the patient is admitted.

Can hospitals in China treat stage 4 cancer?

Yes, hospitals in China treat stage 4 cancer. Treatment can control the cancer, ease symptoms and help you live as well as possible. The plan depends on the cancer type, where it has spread and your general health. China’s lung cancer guideline includes palliative radiotherapy and chemotherapy. Palliative care can start early, alongside cancer treatment. No hospital can promise a cure, so ask the team what they expect in your case.

Did China find a cure for cancer?

No single treatment cures every kind of cancer. Some cancers can be cured, especially when they are found early. For other cancers, treatment aims to control the disease and ease symptoms. China has approved new medicines, such as CAR-T for some blood cancers and for one stomach cancer (CLDN18.2-positive). They help only some patients. Ask your doctor what is realistic for your cancer.

Is CAR-T safe? What are the side effects?

CAR-T can cause serious side effects. These include cytokine release syndrome (fever, low blood pressure and breathing problems) and nervous-system problems. A trained hospital team gives CAR-T and follows you closely. Monitoring rules differ by product. The 2024 Chinese guide describes at least 10 days of monitoring in a trained facility and four weeks living nearby after axicabtagene ciloleucel treatment. It describes daily nervous-system checks for 14 days and four weeks living nearby after zevorcabtagene autoleucel treatment. Ask the hospital for the plan for your product.

Which hospitals in China offer proton or carbon-ion therapy?

Seven hospitals in China offer proton therapy, carbon-ion therapy or both. Two are in Shanghai, and one each is in Wuhan, Hefei, Zibo (Shandong), Zhuozhou (Hebei) and Wuwei (Gansu). Carbon-ion therapy is offered in Shanghai and in Wuwei, whose heavy-ion centre in Lanzhou opened in 2024. The proton and heavy-ion table on this page links each hospital’s own post and, where found, its NMPA device registration. Ask the centre whether your cancer type and stage suit this treatment.

Which cancers can CAR-T treat in China?

CAR-T products are approved in China for some patients with large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, B-cell leukaemia, multiple myeloma or CLDN18.2-positive stomach cancer. Most are used after the cancer comes back or does not respond to earlier treatment. Some have narrower limits. For example, the stomach cancer product is for HER2-negative tumours after at least two earlier treatments. Ask the hospital which approved product fits your case.

Can traditional Chinese medicine cure cancer?

No, traditional Chinese medicine (TCM) is not a proven cure for cancer on its own. It should not replace standard cancer treatment. Tell your cancer team about every TCM product, herb and supplement you use, because some can interact with cancer medicines.

Can foreigners join clinical trials in China?

It depends on the trial. Before you travel, ask the study team if you meet its rules and if consent, communication and follow-up can be arranged. In drug-registration trials under China’s rules, the sponsor must give the trial medicines free and pay for trial-related medical tests. Other care and travel are not free, so ask for all costs in writing.

How do I check a cancer hospital in China?

Check its national titles on this page, its hospital grade and its licence. Our guide explains how Chinese hospitals are classified.

Medical answers reviewed by Dr. Arif Shah, MBBS · 2026-11-16.

Get help choosing a hospital

Tell us your diagnosis and recent test results. Our care team will suggest suitable hospitals from this list, explain the likely costs, and can arrange a medical interpreter in 48 Chinese cities.

WhatsApp Telegram Botim +880 1886 927106 WeChat ID alifa-health

WhatsApp and Telegram: +86 135 2232 3808. You can also use the live chat on this site at any time. We guide and arrange; treatment decisions stay with you and your doctors.